Socioeconomic status as a potential mediator of arterial aging in marginalized ethnic and racial groups: current understandings and future directions.

Sanna Darvish, Sophia A Mahoney, Ravinandan Venkatasubramanian, Matthew J Rossman, Zachary S Clayton, Kevin O Murray
Author Information
  1. Sanna Darvish: Department of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado, United States. ORCID
  2. Sophia A Mahoney: Department of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado, United States.
  3. Ravinandan Venkatasubramanian: Department of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado, United States.
  4. Matthew J Rossman: Department of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado, United States. ORCID
  5. Zachary S Clayton: Department of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado, United States. ORCID
  6. Kevin O Murray: Department of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado, United States. ORCID

Abstract

Cardiovascular diseases (CVDs) are the leading cause of death in the United States. However, disparities in CVD-related morbidity and mortality exist as marginalized racial and ethnic groups are generally at higher risk for CVDs (Black Americans, Indigenous People, South and Southeast Asians, Native Hawaiians, and Pacific Islanders) and/or development of traditional CVD risk factors (groups above plus Hispanics/Latinos) relative to non-Hispanic Whites (NHW). In this comprehensive review, we outline emerging evidence suggesting these groups experience accelerated arterial dysfunction, including vascular endothelial dysfunction and large elastic artery stiffening, a nontraditional CVD risk factor that may predict risk of CVDs in these groups with advancing age. Adverse exposures to social determinants of health (SDOH), specifically lower socioeconomic status (SES), are exacerbated in most of these groups (except South Asians-higher SES) and may be a potential mediator of accelerated arterial aging. SES negatively influences the ability of marginalized racial and ethnic groups to meet aerobic exercise guidelines, the first-line strategy to improve arterial function, due to increased barriers, such as time and financial constraints, lack of motivation, facility access, and health education, to performing conventional aerobic exercise. Thus, identifying alternative interventions to conventional aerobic exercise that ) overcome these common barriers and ) target the biological mechanisms of aging to improve arterial function may be an effective, alternative method to aerobic exercise to ameliorate accelerated arterial aging and reduce CVD risk. Importantly, dedicated efforts are needed to assess these strategies in randomized-controlled clinical trials in these marginalized racial and ethnic groups.

Keywords

References

  1. J Physiol. 2021 Feb;599(3):911-925 [PMID: 33103241]
  2. Heart. 2003 Jun;89(6):681-6 [PMID: 12748237]
  3. Inflamm Regen. 2022 Jan 10;42(1):2 [PMID: 35012677]
  4. J Physiol. 2018 Jul;596(14):2635-2636 [PMID: 29786836]
  5. Soc Sci (Basel). 2016 Mar;5(1): [PMID: 27713839]
  6. Circ Res. 2016 Nov 11;119(11):1204-1214 [PMID: 27780829]
  7. Prev Med. 2012 Oct;55(4):276-284 [PMID: 22846506]
  8. Int Q Community Health Educ. 2013;34(4):391-414 [PMID: 25228486]
  9. Arterioscler Thromb Vasc Biol. 2005 May;25(5):932-43 [PMID: 15731494]
  10. BMC Public Health. 2019 Dec 23;19(1):1726 [PMID: 31870352]
  11. Clin Sci (Lond). 2011 Jan;120(1):13-23 [PMID: 20642454]
  12. BMC Public Health. 2015 Dec 29;15:1312 [PMID: 26715537]
  13. Curr Cardiovasc Risk Rep. 2023 Mar;17(3):73-82 [PMID: 37009309]
  14. J Adv Pract Oncol. 2022 Apr;13(3):221-225 [PMID: 35663187]
  15. J Sci Med Sport. 2019 Apr;22(4):385-391 [PMID: 30803498]
  16. Circulation. 2022 Jul 19;146(3):211-228 [PMID: 35861764]
  17. PLoS One. 2016 Jan 25;11(1):e0147735 [PMID: 26808440]
  18. J Psychoactive Drugs. 2011 Oct-Dec;43(4):343-8 [PMID: 22400467]
  19. JAMA. 2020 May 12;323(18):1852-1854 [PMID: 32396176]
  20. Am J Med Sci. 1999 Mar;317(3):142-6 [PMID: 10100686]
  21. Appl Physiol Nutr Metab. 2016 Feb;41(2):150-6 [PMID: 26761621]
  22. J Am Heart Assoc. 2021 Feb 2;10(3):e017416 [PMID: 33470142]
  23. Exp Gerontol. 2023 Mar;173:112105 [PMID: 36731386]
  24. Mol Med Rep. 2017 May;15(5):3425-3429 [PMID: 28350135]
  25. Pathol Oncol Res. 2013 Jul;19(3):375-83 [PMID: 23242567]
  26. Gerontol Geriatr Med. 2016 Nov 16;2:2333721416677399 [PMID: 28138500]
  27. Clin Epigenetics. 2021 Mar 16;13(1):55 [PMID: 33726838]
  28. Nat Rev Drug Discov. 2008 Feb;7(2):156-67 [PMID: 18167491]
  29. Circ Cardiovasc Qual Outcomes. 2024 Jan;17(1):e000124 [PMID: 38073532]
  30. J Appl Physiol (1985). 2013 May 15;114(10):1375-82 [PMID: 23471944]
  31. J Community Health Nurs. 2013;30(4):185-200 [PMID: 24219639]
  32. Integr Blood Press Control. 2024 Mar 18;17:21-37 [PMID: 38523733]
  33. Hypertens Res. 2022 Feb;45(2):380-381 [PMID: 34857898]
  34. Am J Physiol Heart Circ Physiol. 2014 Feb;306(3):H348-55 [PMID: 24322608]
  35. J Urban Health. 2018 Dec;95(6):801-812 [PMID: 29987772]
  36. Clin Sci (Lond). 2020 Jun 26;134(12):1491-1519 [PMID: 32584404]
  37. Eur Heart J. 2010 Nov;31(22):2808-15 [PMID: 20736241]
  38. EClinicalMedicine. 2020 Dec;29:100630 [PMID: 33200120]
  39. JAMA. 2021 Aug 17;326(7):621-627 [PMID: 34402850]
  40. Circulation. 2018 Jul 3;138(1):e1-e34 [PMID: 29794080]
  41. Exp Physiol. 2015 Sep;100(9):1030-8 [PMID: 26110437]
  42. Am J Physiol Heart Circ Physiol. 2017 Nov 1;313(5):H890-H895 [PMID: 28971843]
  43. Ann Epidemiol. 2019 Feb;30:57-65 [PMID: 30551973]
  44. J Lifestyle Med. 2023 Feb 28;13(1):27-43 [PMID: 37250275]
  45. JACC CardioOncol. 2020 Sep;2(3):475-488 [PMID: 33073250]
  46. JAMA Netw Open. 2022 Apr 1;5(4):e226370 [PMID: 35404461]
  47. Arterioscler Thromb Vasc Biol. 2014 Jun;34(6):1320-7 [PMID: 24675657]
  48. Prev Med. 2004 Nov;39(5):1056-61 [PMID: 15475041]
  49. J Lat Psychol. 2016 May;4(2):98-113 [PMID: 27429866]
  50. Hypertension. 2007 Nov;50(5):970-6 [PMID: 17875820]
  51. Am J Prev Cardiol. 2022 Apr 06;10:100341 [PMID: 35478931]
  52. J Physiol. 2018 Oct;596(20):4831-4845 [PMID: 30118148]
  53. Antioxid Redox Signal. 2011 Sep 15;15(6):1583-606 [PMID: 21473702]
  54. J Am Coll Cardiol. 2012 Nov 20;60(21):2167-9 [PMID: 23103034]
  55. J Am Heart Assoc. 2023 Sep 5;12(17):e030030 [PMID: 37646212]
  56. J Rural Health. 2002 Spring;18(2):319-36 [PMID: 12135153]
  57. JAMA Netw Open. 2023 Sep 5;6(9):e2334923 [PMID: 37738051]
  58. Circ Cardiovasc Qual Outcomes. 2022 Jan;15(1):e007917 [PMID: 35041484]
  59. Heredity (Edinb). 2010 Jul;105(1):4-13 [PMID: 20461105]
  60. EBioMedicine. 2022 Mar;77:103893 [PMID: 35219085]
  61. PLoS One. 2019 May 10;14(5):e0216112 [PMID: 31075120]
  62. Int J Hypertens. 2013;2013:538017 [PMID: 23691280]
  63. Circ Res. 2017 Jun 9;120(12):1855-1856 [PMID: 28596167]
  64. Hawaii Med J. 2009 Aug;68(7):152-7 [PMID: 19653416]
  65. Cell. 2023 Jan 19;186(2):243-278 [PMID: 36599349]
  66. Nat Rev Cardiol. 2020 Sep;17(9):533-535 [PMID: 32732989]
  67. Prev Chronic Dis. 2007 Oct;4(4):A102 [PMID: 17875246]
  68. J Am Heart Assoc. 2020 Jan 21;9(2):e013915 [PMID: 31910779]
  69. PLoS One. 2023 Aug 24;18(8):e0290118 [PMID: 37616275]
  70. Atherosclerosis. 2022 Oct;358:29-33 [PMID: 36049291]
  71. Hypertension. 2022 Dec;79(12):e144-e146 [PMID: 36176038]
  72. Curr Psychiatry Rep. 2018 Sep 17;20(11):95 [PMID: 30221308]
  73. J Appl Physiol (1985). 2018 Nov 1;125(5):1646-1659 [PMID: 30236049]
  74. Soc Sci Med. 2005 Jan;60(1):191-204 [PMID: 15482878]
  75. Open Access J Sports Med. 2018 Jan 26;9:1-17 [PMID: 29416382]
  76. Lipids Health Dis. 2019 Feb 4;18(1):42 [PMID: 30717757]
  77. Stroke. 1995 Mar;26(3):386-91 [PMID: 7886711]
  78. Women Health. 2015;55(6):679-99 [PMID: 25909603]
  79. Womens Health (Lond). 2009 Mar;5(2):127-33 [PMID: 19245351]
  80. Med Sci Sports Exerc. 2017 Jul;49(7):1404-1411 [PMID: 28166118]
  81. Arterioscler Thromb. 1994 Oct;14(10):1631-40 [PMID: 7918314]
  82. J Clin Hypertens (Greenwich). 2021 Jun;23(6):1099-1103 [PMID: 33951308]
  83. J Intern Med. 2021 Aug;290(2):437-443 [PMID: 33651387]
  84. J Am Heart Assoc. 2021 Jul 6;10(13):e019993 [PMID: 34212760]
  85. Prev Med. 2016 Feb;83:11-5 [PMID: 26656406]
  86. Med Sci Sports Exerc. 2016 Jan;48(1):90-7 [PMID: 26225767]
  87. Circulation. 2020 Jun 23;141(25):e948-e959 [PMID: 32460555]
  88. Circulation. 2017 Nov 21;136(21):e393-e423 [PMID: 29061565]
  89. Am J Physiol Heart Circ Physiol. 2023 Jul 1;325(1):H187-H194 [PMID: 37326998]
  90. J Appl Physiol (1985). 2008 Oct;105(4):1323-32 [PMID: 18583377]
  91. Am J Hypertens. 2004 Apr;17(4):304-13 [PMID: 15062883]
  92. Annu Rev Public Health. 2003;24:83-110 [PMID: 12668755]
  93. AMA J Ethics. 2021 Feb 1;23(2):E109-116 [PMID: 33635190]
  94. J Phys Act Health. 2013 Nov;10(8):1119-27 [PMID: 23223757]
  95. Int J Environ Res Public Health. 2021 Jun 22;18(13): [PMID: 34206463]
  96. J Okla State Med Assoc. 2001 Oct;94(10):455-60 [PMID: 11642001]
  97. J Am Heart Assoc. 2023 Mar 7;12(5):e027919 [PMID: 36802713]
  98. JAMA Netw Open. 2021 Dec 1;4(12):e2138920 [PMID: 34910150]
  99. BMJ. 2018 Aug 29;362:k3310 [PMID: 30158148]
  100. Int J Geriatr Psychiatry. 2022 Jan;37(2): [PMID: 35015319]
  101. Circ Res. 2023 Jun 9;132(12):1648-1662 [PMID: 37289899]
  102. Diabetes Res Clin Pract. 2010 Jul;89(1):65-71 [PMID: 20392507]
  103. Prev Med Rep. 2017 Nov 09;8:242-249 [PMID: 29181296]
  104. J Psychosom Res. 2012 Jul;73(1):53-8 [PMID: 22691560]
  105. J Am Coll Cardiol. 2019 Sep 3;74(9):1237-1263 [PMID: 31466622]
  106. Pulse (Basel). 2013 Apr;1(1):14-28 [PMID: 26587425]
  107. Br J Sports Med. 2013 Apr;47(6):393-6 [PMID: 22267567]
  108. Signal Transduct Target Ther. 2022 Jun 25;7(1):200 [PMID: 35752619]
  109. Circulation. 2015 Sep 1;132(9):873-98 [PMID: 26240271]
  110. Disabil Rehabil. 2018 Mar;40(5):538-547 [PMID: 27927028]
  111. Eur J Cardiovasc Nurs. 2017 Aug;16(6):522-529 [PMID: 28756695]
  112. Postgrad Med J. 2007 Feb;83(976):109-14 [PMID: 17308214]
  113. Ethn Dis. 2013 Winter;23(1):35-42 [PMID: 23495620]
  114. Atherosclerosis. 1999 Oct;146(2):243-8 [PMID: 10532680]
  115. J Am Heart Assoc. 2023 Feb 21;12(4):e026790 [PMID: 36789849]
  116. Hawaii J Med Public Health. 2017 Mar;76(3 Suppl 1):36-41 [PMID: 28435757]
  117. Diabetes Care. 2012 Jul;35(7):1492-8 [PMID: 22619080]
  118. Clin Endocrinol (Oxf). 2003 Dec;59(6):811-6 [PMID: 14974927]
  119. Australas J Ageing. 2020 Dec;39(4):331-340 [PMID: 32597566]
  120. J Gend Specif Med. 2002 Mar-Apr;5(2):27-37 [PMID: 11974672]
  121. Curr Cardiol Rep. 2014 May;16(5):476 [PMID: 24643902]
  122. Am J Epidemiol. 1990 Dec;132(6):1141-55 [PMID: 2260546]
  123. Physiol Rep. 2019 Jul;7(12):e14139 [PMID: 31207144]
  124. Circ Res. 2018 Sep 14;123(7):825-848 [PMID: 30355078]
  125. Cardiol Rev. 2007 Jan-Feb;15(1):35-41 [PMID: 17172882]
  126. Toxicol Res. 2014 Jun;30(2):71-5 [PMID: 25071915]
  127. Hawaii Med J. 2005 Oct;64(10):270, 272-3 [PMID: 16294701]
  128. Front Cardiovasc Med. 2022 Nov 17;9:1046560 [PMID: 36465439]
  129. J Am Heart Assoc. 2023 Apr 4;12(7):e028529 [PMID: 36994741]
  130. Artery Res. 2020;27(2):59 [PMID: 35414837]
  131. Am J Public Health. 1987 Jan;77(1):61-8 [PMID: 3789240]
  132. Front Physiol. 2019 Jun 06;10:645 [PMID: 31244666]
  133. JAMA. 2012 Nov 7;308(17):1775-84 [PMID: 23117778]
  134. J Womens Health (Larchmt). 2014 Mar;23(3):260-6 [PMID: 24299160]
  135. J Am Heart Assoc. 2021 Jul 6;10(13):e020408 [PMID: 34182790]
  136. Am J Public Health. 2014 Jun;104 Suppl 3:S303-11 [PMID: 24754554]
  137. Psychiatr Serv. 2016 Feb;67(2):234-5 [PMID: 26522677]
  138. J Am Geriatr Soc. 2023 Sep;71(9):2845-2854 [PMID: 37073412]
  139. J Nucl Cardiol. 2020 Dec;27(6):2375-2385 [PMID: 30793251]
  140. J Am Coll Cardiol. 2014 Dec 16;64(23):2486-94 [PMID: 25500233]
  141. Circ Cardiovasc Qual Outcomes. 2017 Feb;10(2): [PMID: 28228456]
  142. Circ Cardiovasc Qual Outcomes. 2023 Apr;16(4):e009697 [PMID: 37017086]
  143. JAMA Intern Med. 2017 Aug 1;177(8):1165-1172 [PMID: 28604921]
  144. Exp Gerontol. 2014 Oct;58:78-82 [PMID: 25034910]
  145. JAMA. 1996 Sep 11;276(10):792-7 [PMID: 8769588]
  146. Clin Diabetes. 2017 Jan;35(1):66-70 [PMID: 28144049]
  147. Am J Physiol Heart Circ Physiol. 2024 May 1;326(5):H1279-H1290 [PMID: 38517225]
  148. Asia Pac J Clin Nutr. 2008;17(3):375-84 [PMID: 18818156]
  149. Hypertension. 2018 Jun;71(6):1056-1063 [PMID: 29661838]
  150. J Am Heart Assoc. 2020 May 5;9(9):e017112 [PMID: 32342721]
  151. J Phys Act Health. 2011 Sep;8(7):916-25 [PMID: 21885882]
  152. Int J Equity Health. 2022 May 2;21(1):58 [PMID: 35501912]
  153. J Gen Intern Med. 2015 Aug;30(8):1118-24 [PMID: 25715993]
  154. Appl Physiol Nutr Metab. 2021 May;46(5):521-529 [PMID: 33242251]
  155. Aging Cell. 2023 Jan;22(1):e13750 [PMID: 36539941]
  156. Hypertension. 2018 Oct;72(4):796-805 [PMID: 30354723]
  157. Nat Rev Mol Cell Biol. 2007 Sep;8(9):729-40 [PMID: 17667954]
  158. Am J Hypertens. 2014 Mar;27(3):415-21 [PMID: 24280041]
  159. BMC Public Health. 2011 Jun 28;11:507 [PMID: 21711514]
  160. J Health Care Poor Underserved. 2002 Nov;13(4):477-503 [PMID: 12407964]
  161. Clin Transl Sci. 2011 Feb;4(1):32-7 [PMID: 21348953]
  162. Circulation. 2018 Feb 20;137(8):854-864 [PMID: 29459471]
  163. Circulation. 2021 Jun 15;143(24):2346-2354 [PMID: 34000814]
  164. Am J Prev Cardiol. 2021 Apr 18;6:100185 [PMID: 34327505]
  165. Aust N Z J Public Health. 2019 Oct;43(5):443-450 [PMID: 31091346]
  166. Environ Int. 2018 Dec;121(Pt 1):139-147 [PMID: 30205320]
  167. Eur J Gen Pract. 2017 Dec;23(1):59-68 [PMID: 28271920]
  168. Public Health Rep. 2014 Jan-Feb;129 Suppl 2:19-31 [PMID: 24385661]
  169. Clin Med Res. 2014 Sep;12(1-2):10-20 [PMID: 24415748]
  170. Appl Physiol Nutr Metab. 2019 Jun;44(6):681-684 [PMID: 30649897]
  171. Arterioscler Thromb Vasc Biol. 2023 Nov;43(11):2099-2114 [PMID: 37706319]
  172. J Am Heart Assoc. 2017 Jun 21;6(6): [PMID: 28637779]
  173. Perspect Psychol Sci. 2021 Nov;16(6):1324-1336 [PMID: 33621473]
  174. J Am Heart Assoc. 2019 Feb 19;8(4):e010825 [PMID: 30741602]
  175. Prev Chronic Dis. 2004 Oct;1(4):A09 [PMID: 15670441]
  176. J Hypertens. 2016 Oct;34(10):2038-44 [PMID: 27442790]
  177. Am J Prev Cardiol. 2023 Jan 26;13:100469 [PMID: 36798726]
  178. Circulation. 2023 May 9;147(19):1471-1487 [PMID: 37035919]
  179. J Biomed Sci Eng. 2022 Nov;15(11):261-268 [PMID: 36419938]
  180. Atherosclerosis. 2016 May;248:97-109 [PMID: 26994427]
  181. Hypertension. 2011 Mar;57(3):363-9 [PMID: 21263128]
  182. Circulation. 2019 Mar 5;139(10):e56-e528 [PMID: 30700139]
  183. Hypertens Res. 2008 Feb;31(2):377-81 [PMID: 18360058]
  184. Exerc Sport Sci Rev. 2013 Jan;41(1):44-54 [PMID: 23262464]
  185. JAMA Netw Open. 2021 Nov 1;4(11):e2134147 [PMID: 34762110]
  186. Med Sci Sports Exerc. 2020 May;52(5):1057-1067 [PMID: 31876667]
  187. J Am Heart Assoc. 2021 Jun;10(11):e020997 [PMID: 34006116]
  188. Hypertension. 2005 Jun;45(6):1107-12 [PMID: 15867135]
  189. N Engl J Med. 1999 Jan 7;340(1):14-22 [PMID: 9878640]
  190. Ann Behav Med. 2021 Oct 4;55(10):1006-1018 [PMID: 33677520]
  191. J Am Coll Cardiol. 2010 Dec 14;56(25):e50-103 [PMID: 21144964]
  192. Aging Clin Exp Res. 2022 Jun;34(6):1215-1223 [PMID: 35132578]
  193. Circulation. 2004 Feb 10;109(5):613-9 [PMID: 14769683]
  194. Curr Cardiovasc Risk Rep. 2019 Apr;13(4): [PMID: 31482004]
  195. Geroscience. 2024 Jun;46(3):3311-3324 [PMID: 38265578]
  196. Nat Rev Cardiol. 2023 Nov;20(11):754-777 [PMID: 37193857]
  197. BMC Med. 2018 Nov 29;16(1):219 [PMID: 30486813]
  198. Asia Pac J Clin Nutr. 2001;10(3):188-93 [PMID: 11708306]
  199. JAMA. 2005 Dec 14;294(22):2879-88 [PMID: 16352796]
  200. Hypertension. 2023 Oct;80(10):2072-2087 [PMID: 37593877]
  201. Ann Behav Med. 2010 Jun;39(3):222-31 [PMID: 20376585]
  202. Oman Med J. 2020 Apr 30;35(2):e122 [PMID: 32411417]
  203. Curr Treat Options Cardiovasc Med. 2020;22(12):75 [PMID: 33223802]
  204. J Am Heart Assoc. 2019 Sep 3;8(17):e013165 [PMID: 31476920]
  205. Circulation. 2018 May 15;137(20):2166-2178 [PMID: 29760227]
  206. Int J MCH AIDS. 2021;10(1):7-18 [PMID: 33442488]
  207. J Biomed Sci. 2014 Jan 13;21:3 [PMID: 24410814]
  208. Soc Sci Med. 2001 Feb;52(3):441-51 [PMID: 11330778]
  209. Int J Obes (Lond). 2018 Jun;42(6):1112-1126 [PMID: 29795462]
  210. Int J Obes (Lond). 2015 Aug;39(8):1217-23 [PMID: 25869608]
  211. Psychosom Med. 2005 Sep-Oct;67(5):692-6 [PMID: 16204425]
  212. Eur J Appl Physiol. 2019 May;119(5):1203-1212 [PMID: 30847639]
  213. J Am Heart Assoc. 2022 Apr 5;11(7):e022857 [PMID: 35362334]
  214. Br J Cancer. 2021 Jan;124(2):315-332 [PMID: 32901135]
  215. J Hum Resour. 2008 Summer;43(3):630-659 [PMID: 26097255]
  216. JAMA Cardiol. 2020 Aug 1;5(8):899-908 [PMID: 32459344]
  217. Int J Behav Nutr Phys Act. 2012 Sep 19;9:116 [PMID: 22992350]
  218. Sci Rep. 2022 Nov 14;12(1):19475 [PMID: 36376533]
  219. Am J Public Health. 1994 Jun;84(6):971-6 [PMID: 8203695]
  220. Heart Fail Rev. 2024 Jul;29(4):827-839 [PMID: 38619757]
  221. Aging Cell. 2011 Dec;10(6):1032-7 [PMID: 21943306]
  222. Lancet. 2014 Mar 15;383(9921):999-1008 [PMID: 24084292]
  223. Clin Sci (Lond). 2018 Aug 30;132(16):1765-1777 [PMID: 29914938]
  224. JRSM Cardiovasc Dis. 2012 Jul 31;1(4): [PMID: 24175067]
  225. Arterioscler Thromb Vasc Biol. 1998 Jan;18(1):127-32 [PMID: 9445266]
  226. Int J Cardiol Hypertens. 2021 Apr 28;9:100085 [PMID: 34095811]
  227. Glob Public Health. 2022 Dec;17(12):3944-3966 [PMID: 32816635]
  228. Circulation. 2014 Aug 12;130(7):593-625 [PMID: 25098323]
  229. J Rural Health. 2021 Jan;37(1):256-259 [PMID: 32744339]
  230. J Am Coll Cardiol. 2002 Aug 21;40(4):754-60 [PMID: 12204507]
  231. EClinicalMedicine. 2022 Feb 11;44:101297 [PMID: 35198921]
  232. Sci Rep. 2017 Sep 28;7(1):12370 [PMID: 28959022]
  233. J Health Soc Behav. 1995;Spec No:80-94 [PMID: 7560851]
  234. Circulation. 2004 Jun 1;109(21):2511-7 [PMID: 15159296]
  235. N Z Med J. 2008 Sep 05;121(1281):28-39 [PMID: 18797481]
  236. Ann Epidemiol. 2010 Aug;20(8):617-28 [PMID: 20609342]
  237. Ther Adv Endocrinol Metab. 2019 Dec 24;10:2042018819897046 [PMID: 31903180]
  238. Public Health Rev. 2018 Dec 3;39:32 [PMID: 30524764]
  239. Am J Physiol Heart Circ Physiol. 2021 Apr 1;320(4):H1440-H1455 [PMID: 33606580]
  240. Redox Biol. 2023 Jul;63:102718 [PMID: 37120928]
  241. Am J Hypertens. 2020 Oct 21;33(10):962-963 [PMID: 32179911]
  242. Health Serv Res. 2019 Dec;54 Suppl 2:1419-1430 [PMID: 31657465]
  243. Circulation. 2024 Feb 20;149(8):e347-e913 [PMID: 38264914]
  244. SSM Popul Health. 2021 Jan 12;13:100733 [PMID: 33532540]
  245. Nat Commun. 2018 Mar 29;9(1):1286 [PMID: 29599478]
  246. Stroke. 1994 Jan;25(1):11-6 [PMID: 8266356]
  247. Int J Environ Res Public Health. 2022 Jul 24;19(15): [PMID: 35897374]
  248. J Pediatr. 2007 Apr;150(4):400-6 [PMID: 17382119]
  249. Circulation. 2022 Jul 19;146(3):229-239 [PMID: 35861763]
  250. Arterioscler Thromb Vasc Biol. 2021 May 5;41(5):1760-1773 [PMID: 33626910]
  251. Heliyon. 2023 Jan 24;9(2):e13180 [PMID: 36798760]
  252. Popul Today. 1993 Feb;21(2):3, 10 [PMID: 12286198]
  253. Annu Rev Physiol. 2013;75:685-705 [PMID: 23140366]
  254. Hypertension. 2021 Apr;77(4):1212-1222 [PMID: 33641356]
  255. Hawaii J Med Public Health. 2019 Feb;78(2):61-65 [PMID: 30766766]
  256. Eur J Prev Cardiol. 2020 Mar;27(5):457-472 [PMID: 31450966]
  257. J Hypertens. 2015 Dec;33(12):2477-82 [PMID: 26378681]
  258. Medicine (Baltimore). 2016 Aug;95(32):e4409 [PMID: 27512854]
  259. Int J Environ Res Public Health. 2018 Nov 18;15(11): [PMID: 30453690]
  260. J Am Heart Assoc. 2021 Jul 6;10(13):e020980 [PMID: 34184544]
  261. Circ Res. 2021 Apr 2;128(7):864-886 [PMID: 33793325]
  262. Int J Environ Res Public Health. 2014 Nov 21;11(11):12053-63 [PMID: 25421064]
  263. Am J Public Health. 2012 Aug;102(8):1572-8 [PMID: 22698012]
  264. Circulation. 2001 Nov 27;104(22):2673-8 [PMID: 11723017]
  265. Int Arch Occup Environ Health. 2015 Aug;88(6):707-16 [PMID: 25385250]
  266. Circulation. 2022 Feb 22;145(8):e153-e639 [PMID: 35078371]
  267. JAMA. 2019 Nov 26;322(20):1996-2016 [PMID: 31769830]
  268. Nat Rev Cardiol. 2020 Oct;17(10):656-672 [PMID: 32382149]
  269. Hypertension. 2001 May;37(5):1236-41 [PMID: 11358934]
  270. Am J Physiol Heart Circ Physiol. 2019 Oct 1;317(4):H777-H789 [PMID: 31397168]
  271. J Cardiovasc Aging. 2022;2: [PMID: 36337728]
  272. Circulation. 2020 Dec 15;142(24):e454-e468 [PMID: 33170755]
  273. JAMA Intern Med. 2021 Sep 1;181(9):1207-1215 [PMID: 34309621]
  274. J Am Heart Assoc. 2020 May 5;9(9):e015697 [PMID: 32340506]
  275. Ethn Dis. 2014 Summer;24(3):283-9 [PMID: 25065068]
  276. J Health Soc Behav. 2010;51 Suppl:S28-40 [PMID: 20943581]
  277. JAMA Netw Open. 2023 Feb 1;6(2):e230561 [PMID: 36826819]
  278. J Am Coll Cardiol. 2022 Apr 12;79(14):1388-1397 [PMID: 35393021]
  279. Health Equity. 2019 Oct 24;3(1):527-531 [PMID: 31656940]
  280. Cardiol Clin. 2017 May;35(2):223-230 [PMID: 28411896]
  281. Prev Chronic Dis. 2019 Apr 11;16:E46 [PMID: 30974071]
  282. Curr Diab Rep. 2013 Dec;13(6):814-23 [PMID: 24037313]
  283. Ethn Dis. 2014 Spring;24(2):133-43 [PMID: 24804357]
  284. J Health Soc Behav. 2003 Sep;44(3):318-31 [PMID: 14582311]
  285. Am J Prev Med. 2010 Apr;38(4):439-42 [PMID: 20307813]
  286. Curr Hypertens Rep. 2017 Oct 18;19(11):90 [PMID: 29046980]
  287. LGBT Health. 2021 Jul;8(5):330-339 [PMID: 34101498]
  288. JAMA. 2021 Oct 5;326(13):1286-1298 [PMID: 34609450]
  289. J Am Heart Assoc. 2023 Mar 21;12(6):e027620 [PMID: 36926993]
  290. Circulation. 2004 Oct 12;110(15):2266-75 [PMID: 15477426]
  291. Glob Cardiol Sci Pract. 2014 Oct 16;2014(3):291-308 [PMID: 25780786]
  292. Arterioscler Thromb Vasc Biol. 2020 May;40(5):1044-1054 [PMID: 32237903]
  293. Prev Med Rep. 2019 Jul 13;15:100952 [PMID: 31367514]
  294. Circulation. 2006 Feb 7;113(5):664-70 [PMID: 16461839]
  295. Circulation. 2015 Jan 13;131(2):141-8 [PMID: 25447044]
  296. Diabetologia. 2019 Jun;62(6):905-914 [PMID: 30843102]
  297. Curr Sports Med Rep. 2013 Jul-Aug;12(4):215-7 [PMID: 23851406]
  298. Public Health Nurs. 2011 Sep-Oct;28(5):389-401 [PMID: 22092422]
  299. J Am Heart Assoc. 2023 Dec 5;12(23):e030695 [PMID: 38038179]
  300. Am J Epidemiol. 1991 Aug 1;134(3):250-6 [PMID: 1877584]
  301. Int J Cardiol Heart Vasc. 2020 Aug 05;30:100598 [PMID: 32793802]
  302. Stroke. 2017 Apr;48(4):850-856 [PMID: 28235961]
  303. Curr Cardiol Rev. 2015;11(3):238-45 [PMID: 25418513]
  304. J Am Heart Assoc. 2024 Apr 16;13(8):e031444 [PMID: 38606778]
  305. Int J Epidemiol. 2020 Feb 1;49(1):25-35 [PMID: 31289812]
  306. Clin Cardiol. 2013 Dec;36(12):713-720 [PMID: 24194499]
  307. Health Commun. 2022 Aug;37(9):1204-1214 [PMID: 33853460]
  308. Circ Res. 2018 Sep 14;123(7):849-867 [PMID: 30355080]
  309. Cardiovasc Toxicol. 2016 Jul;16(3):260-75 [PMID: 26148452]
  310. J Am Coll Cardiol. 2021 Jun 29;77(25):3195-3216 [PMID: 34167645]
  311. Exp Physiol. 2022 Jul;107(7):694-707 [PMID: 33904234]
  312. Circ Res. 2022 Mar 4;130(5):782-799 [PMID: 35239404]
  313. Hypertension. 2017 Oct;70(4):729-735 [PMID: 28808067]
  314. Circulation. 1993 Oct;88(4 Pt 1):1456-62 [PMID: 8403292]
  315. Hypertension. 2022 May;79(5):1045-1056 [PMID: 35168368]
  316. Circulation. 2020 Nov 10;142(19):e321-e332 [PMID: 33028085]
  317. J Appl Physiol (1985). 2020 Sep 1;129(3):449-458 [PMID: 32730174]
  318. J Ambul Care Manage. 2009 Oct-Dec;32(4):264-70 [PMID: 19887997]
  319. J Epidemiol Community Health. 2015 Feb;69(2):136-41 [PMID: 25271247]
  320. J Racial Ethn Health Disparities. 2017 Jun;4(3):397-409 [PMID: 27178447]
  321. Nat Med. 2024 Feb;30(2):330-333 [PMID: 38374344]
  322. Front Physiol. 2012 May 28;3:132 [PMID: 22783194]
  323. Heart Lung Circ. 2024 May;33(5):576-604 [PMID: 38184426]
  324. J Health Care Poor Underserved. 2010 Nov;21(4):1203-14 [PMID: 21099072]
  325. Prog Community Health Partnersh. 2023;17(1):71-78 [PMID: 37462576]
  326. JAMA Netw Open. 2023 Jan 3;6(1):e2250416 [PMID: 36630135]
  327. J Phys Act Health. 2021 Aug 1;18(S1):S45-S52 [PMID: 34465650]
  328. J Physiol. 2016 Sep 15;594(18):5329-42 [PMID: 27270841]
  329. Nat Rev Cardiol. 2023 Apr;20(4):236-247 [PMID: 36316574]
  330. Circ Genom Precis Med. 2021 Aug;14(4):e000084 [PMID: 34304578]
  331. Hypertens Res. 2007 Oct;30(10):895-902 [PMID: 18049020]
  332. JAMA. 1999 Mar 17;281(11):1006-13 [PMID: 10086435]
  333. J Physiol. 2014 Jun 15;592(12):2549-61 [PMID: 24665093]
  334. BMC Public Health. 2012 Jan 25;12:80 [PMID: 22276600]
  335. Clin Cardiol. 2016 Jun;39(6):338-44 [PMID: 27028406]
  336. Prev Chronic Dis. 2019 Feb 21;16:E22 [PMID: 30789820]
  337. Circulation. 2024 Jan 16;149(3):e217-e231 [PMID: 38059362]
  338. Am J Hypertens. 2020 Jan 1;33(1):84-91 [PMID: 31420642]
  339. Medicine (Baltimore). 2015 Aug;94(34):e1441 [PMID: 26313803]
  340. Ann Behav Med. 2020 Oct 1;54(10):761-770 [PMID: 32227162]
  341. Circulation. 2018 Jul 10;138(2):e48-e74 [PMID: 29866648]
  342. Circulation. 2000 Sep 19;102(12):1351-7 [PMID: 10993851]
  343. Circulation. 2010 Feb 2;121(4):505-11 [PMID: 20083680]
  344. Front Endocrinol (Lausanne). 2023 Mar 06;14:1085950 [PMID: 36950689]
  345. J Cardiometab Syndr. 2007 Fall;2(4):250-3 [PMID: 18059207]
  346. Hypertension. 2024 Feb;81(2):e10-e12 [PMID: 38232143]
  347. Annu Rev Sociol. 2010 Aug;36:349-370 [PMID: 21909182]
  348. Geriatrics (Basel). 2020 Nov 19;5(4): [PMID: 33228041]
  349. Health Sci Rev (Oxf). 2022 Sep;4: [PMID: 36438886]
  350. Hypertension. 2011 Nov;58(5):950-8 [PMID: 21896934]
  351. Aging Cell. 2024 Mar;23(3):e14060 [PMID: 38062873]
  352. J Clin Endocrinol Metab. 2013 Nov;98(11):4507-15 [PMID: 24092827]
  353. Aging (Albany NY). 2016 Nov 22;8(11):2897-2914 [PMID: 27875805]

Grants

  1. 24PRE1186290/American Heart Association (AHA)
  2. F31HL165885/HHS | National Institutes of Health (NIH)
  3. 23CDA1056582/American Heart Association (AHA)
  4. K01DK115524/HHS | National Institutes of Health (NIH)
  5. K99HL159241/HHS | National Institutes of Health (NIH)
  6. F32HL167552/HHS | National Institutes of Health (NIH)
  7. 23POST1025630/American Heart Association (AHA)

MeSH Term

Humans
Social Class
Aging
Cardiovascular Diseases
Ethnicity
Arteries
Racial Groups
Risk Factors
Social Determinants of Health

Word Cloud

Created with Highcharts 10.0.0groupsarterialriskagingaerobicexercisemarginalizedracialethnicCVDsCVDacceleratedmaySESfunctiondisparitiesSouthdysfunctionvascularsocialdeterminantshealthstatuspotentialmediatorimprovebarriersconventionalalternativeCardiovasculardiseasesleadingcausedeathUnitedStatesHoweverCVD-relatedmorbiditymortalityexistgenerallyhigherBlackAmericansIndigenousPeopleSoutheastAsiansNativeHawaiiansPacificIslandersand/ordevelopmenttraditionalfactorsplusHispanics/Latinosrelativenon-HispanicWhitesNHWcomprehensivereviewoutlineemergingevidencesuggestingexperienceincludingendotheliallargeelasticarterystiffeningnontraditionalfactorpredictadvancingageAdverseexposuresSDOHspecificallylowersocioeconomicexacerbatedexceptAsians-highernegativelyinfluencesabilitymeetguidelinesfirst-linestrategydueincreasedtimefinancialconstraintslackmotivationfacilityaccesseducationperformingThusidentifyinginterventionsovercomecommontargetbiologicalmechanismseffectivemethodamelioratereduceImportantlydedicatedeffortsneededassessstrategiesrandomized-controlledclinicaltrialsSocioeconomicgroups:currentunderstandingsfuturedirectionsbiology

Similar Articles

Cited By